Brind.

Seeking validation for next-gen pMDIs in Europe.

1 report, 1 independent Updated Sep 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

European Medicines Agency Chiesi

Keep exploring

The entities involved

European Medicines Agency
highest regulatory authority on medicines in the European Union
- IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.Mon 14:18
- Both the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Fri 23:04
Chiesi
Nothing else this week.

Related events

INmune Bio Inc. submitted an Orphan Drug Designation and Scientific Advice package to the European Medicines Agency.Aug 26
Ascletis Pharma expects to submit its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) in early 2029.Aug 30

Coverage

Newest first; wire copies grouped

Sep 3finanznachrichten.de